A randomized controlled trial of lactobacillus GG in children with functional abdominal pain

Pediatrics

Volumn 126, Issue 6, 2010, Pages

  Francavilla, Ruggiero ^a   Miniello, Vito ^a   Magistà, Anna Maria ^a   De Canio, Angela ^a   Bucci, Nunzia ^a   Gagliardi, Francesca ^a   Lionetti, Elena ^b   Castellaneta, Stefania ^c   Polimeno, Lorenzo ^a   Peccarisi, Lucia ^d   Indrio, Flavia ^a   Cavallo, Luciano ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c SAN PAOLO HOSPITAL   (Italy)

^d ASL Bari   (Italy)

Author keywords

Abdominal pain; Intestinal barrier function; Lactobacillus rhamnosus GG; Pediatric gastroenterology; Probiotics

Indexed keywords

PLACEBO; PROBIOTIC AGENT; SUGAR;

ABDOMINAL PAIN; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; INTESTINE MUCOSA PERMEABILITY; IRRITABLE COLON; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE;

ABDOMINAL PAIN; ADOLESCENT; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; IRRITABLE BOWEL SYNDROME; LACTOBACILLUS RHAMNOSUS; MALE; PROBIOTICS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 78649684470     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2010-0467     Document Type: Article

References (43)

1. Scharff L. Recurrent abdominal pain in children: a review of psychological factors and treatment. Clin Psychol Rev. 1997;17(2):145-66 (Pubitemid 27200984)
2. Saps M, Seshadri R, Sztainberg M, Schaffer G, Marshall BM, Di Lorenzo C. A prospective school-based study of abdominal pain and other common somatic complaints in children. J Pediatr. 2009;154(3):322-326
3. Rasquin A, Di Lorenzo C, Forbes D, et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology. 2006;130(5):1527-1537
4. Sanders MR, Shepherd RW, Cleghorn G, Woolford H. The treatment of recurrent abdominal pain in children: a controlled comparison of cognitive-behavioral family intervention and standard pediatric care. J Consult Clin Psychol. 1994;62(2):306-314
5. Weydert JA, Ball TM, Davis MF. Systematic review of treatments for recurrent abdominal pain. Pediatrics. 2003;111(1). Available at: www.pediatrics.org/cgi/content/full/111/1/e1
6. Huertas-Ceballos A, Logan S, Bennett C, Macarthur C. Pharmacological interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database Syst Rev. 2008;(1):CD003017
7. Huertas-Ceballos AA, Logan S, Bennett C, MacarthurC. Dietaryinterventionsforrecurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database Syst Rev. 2009;(21):CD003019
8. Saps M, Youssef N, Miranda A, et al. Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders. Gastroenterology. 2009;137(4):1261-1269
9. Walker WA, Goulet O, Morelli I, et al. Progress in science of probiotics: from cellular microbiology and applied immunology to clinical nutrition. Eur J Nutr. 2006;45(1):1-18 (Pubitemid 44128132)
10. Brown AC, Valiere A. Probiotics and medical nutrition therapy. Nutr Clin Care. 2004;7(2):56-68
11. Lemberg DA, Ooi CY, Day AS. Probiotics in paediatric gastrointestinal diseases. J Paediatr Child Health. 2007;43(5):331-336
12. Silva M, Jacobus NV, Deneke C, Gorbach SL. Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother. 1987;31(8):1311-233
13. O' Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 2005;128(3):415-551
14. Doron S, Snydman DR, Gorbach L. Lactobacillus GG: bacteriology and clinical applications. Gastroenterol Clin N Am. 2005;34(3):483-498
15. Bausserman M, Michail S. The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial. J Pediatr. 2005;147(2):197-201
16. Gawrońska A, Dziechciarz P, Horvath A, Szajewska H. A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment Pharmacol Ther. 2007;25(2):177-184
17. Corazziari E, Bytzer P, Delvauz M, et al. Consensus report: clinical trial guidelines for pharmacological treatment of irritable bowel syndrome. Aliment Pharmcol Ther. 2003;18(6):569-580
18. Rasquin-Weber A, Hyman PE, Cucchiara S, et al. Childhood functional gastrointestinal disorder. Gut. 1999;45(suppl 2):II60-II68
19. McGrath PA, Seifert CE, Speechley KN, Booth JC, Stitt L, Gibson MC. A new analogue scale for assessing children's pain: an initial validation study. Pain. 1996;64(3):435-443 (Pubitemid 26180149)
20. von Baeyer CL. Children's self-reports of pain intensity: scale selection, limitations and interpretation. Pain Res Manag. Autumn. 2006;11(3):157-162
21. Generoso M, De Rosa M, De Rosa R, et al. Cellobiose and lactulose coupled with mannitol and determined using ion-exchange chromatography with pulsed amperometric detection, are reliable probes for investigation of intestinal permeability. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;783(2):349-357 (Pubitemid 35447985)
22. Secondulfo M, Iafusco D, Carratù R, et al. Ultrastructural mucosal alterations and increased intestinal permeability in nonceliac, type 1 diabetic patients. Digest Liver Dis. 2004;36(1):35-45
23. Barbara G, Stanghellini V, Cremon C, et al. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use. J Clin Gastroenterol. 2008;42(suppl 3):S214-S217
24. Jarrett M, Heitkemper M, Czyzewski DI, Shulman R. Recurrent abdominal pain in children: forerunner to adult irritable bowel syndrome? J Soc Pediatr Nurs. 2003;8(3):81-89
25. Hotopf M, Carr S, Mayou R, Wadsworth M, Wessely S. Why do children have chronic abdominal pain, and what happens to them when they grow up? Population based cohort study. BMJ. 1998;316(7139):1196-2000
26. Di Lorenzo C, Youssef NN, Sigurdsson L, Scharff L, Griffiths J, Wald A. Visceral hyperalgesia in children with functional abdominal pain. J Pediatr. 2001;139(6):838-843 (Pubitemid 34014464)
27. Wyatt GM, Bayliss CE, Lakey AF, Bradley HK, Hunter JO, Jones VA. The faecal flora of two patients with food-related irritable bowel syndrome during challenge with symptomprovoking foods. J Med Microbiol. 1988;26(4):295-299
28. Kassinen A, Krogius-Kurikka L, Makivuokko H, et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology. 2007;133(1):24-33
29. Mättö J, Maunuksela L, Kajander K, et al. Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome: a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol. 2005;43(2):213-222 (Pubitemid 40170291)
30. Lammers KM, Brigidi P, Vitali B, et al. Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol. 2003;38(2):165-172 (Pubitemid 37297842)
31. Chen CC, Louie S, Shi HN, Walker WA. Preinoculation with the probiotic Lactobacillus acidophilus early in life effectively inhibits murine Citrobacter rodentium colitis. Pediatr Res. 2005;58(6):1185-1191
32. Rousseaux C, Thuru X, Gelot A, et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med. 2007;13(1):35-37
33. Berger MJ, Gieteling MJ, Benninga MA. Chronic abdominal pain in children. BMJ. 2007;334(7601):997-1002
34. Dunlop SP, Hebden J, Campbell E, et al. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes [published correction appears in Am J Gastroenterol. 2006;101(8):1944]. Am J Gastroenterol. 2006;101(6):1288-1294
35. Marshall JK, Thabane M, Garg AX, et al. Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario. Aliment Pharmacol Ther. 2004; 20(11-12):1317-1322
36. Camilleri M. Gorman H. Intestinal permeability and irritable bowel syndrome. Neurogastroenterol Motil. 2007;19(7):545-552 (Pubitemid 46985594)
37. Shulman RJ, Eakin MN, Czyzewski DI, Jarrett M, Ou CN. Increased gastrointestinal permeability and gut inflammation in children with functional abdominal pain and irritable bowel syndrome. J Pediatr. 2008;153(5):646-650
38. Johnson-Henry KC, Donato KA, Shen-Tu G, Gordanpour M, Sherman PM. Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157: H7-induced changes in epithelial barrier function. Infect Immun. 2008;76(4):1340-1348 (Pubitemid 351561979)
39. Seth A, Yan F, Polk DB, Rao RK. Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism. Am J Physiol Gastrointest Liver Physiol. 2008;294(4):G1060-G1069
40. Isolauri E, Majamaa H, Arvola T, Rantala I, Virtanen E, Arvilommi H. Lactobacillus casei strain GGreversesincreasedintestinal permeability induced by cow milk in suckling rats. Gastroenterology. 1993;105(6):1643-1650
41. Forsyth CB, Farhadi A, Jakate SM, Tang Y, Shaikh M, Keshavarzian A. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol. 2009;43(2):163-172
42. Madsen K, Cornish A, Soper P, et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology. 2001;121(3):580-591
43. Preidis GA, Versalovic J. Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology. 2009;136(6):2015-2031